Gilead Japan Eyes High-Single-Digit Annual Growth with Oncology as Third Biz Pillar

Gilead Japan President Kennet Brysting Gilead Sciences is looking to achieve high-single-digit annual revenue growth in Japan, Kennet Brysting, who took the local helm of the company in January, tells Jiho. The drug maker is set to expand its Japan...read more